ANTG’s $100M Deal Puts Them in NSW Export Awards Spotlight

Australian medicinal cannabis company ANTG has been named a finalist in the Regional Exporter category for the 2024 Premier’s NSW Export Awards. Since its inception in 2016, the company has seen significant growth across Australia, establishing itself as a premier producer of high-quality medical cannabis. Their exclusive $100 million agreement with Germany’s Cannamedical Pharma (CM) highlights their expanding influence in the European market. This recognition not only underscores their domestic success but also their international impact.

From Local Roots to Global Recognition

ANTG started its journey focusing on innovation, sustainability, and excellence in medicinal cannabis.

Their key milestones include:

  • Rapid expansion throughout Australia since 2016.
  • Becoming a leading producer of high-quality medical cannabis.
  • Commitment to advancing the industry through cutting-edge practices.

Their dedication has benefited patients and positioned them as a significant global player.

A $100 Million European Partnership

So, what’s the buzz about their deal with Cannamedical Pharma?

The exclusive agreement with CM, valued at over $100 million, reinforces ANTG’s standing in the European market. CM is the largest independent producer and distributor of medical cannabis in Germany, operating in Europe’s fastest-growing cannabis market. This partnership opens doors to new opportunities and strengthens their international presence.

Boosting the Local Economy

Good news for the Northern Tablelands region!

The increase in production and manufacturing capacity is expected to create up to 45 new local jobs in cultivation and manufacturing. This represents a significant boost for the regional economy, providing employment opportunities and fostering economic growth. It’s a win-win for both the company and the local communities.

Mr. Cantelo emphasized that this expansion marks a major step forward for their domestic operations.

Leading in Cannabis Law Reform

ANTG isn’t just about business; they’re also making strides in law reform.

In 2020, they became the first Australian company to export commercially cultivated flower to Germany. They’ve continued this successful partnership as Germany moves forward with cannabis law reform. In April, comprehensive legislation was passed, removing prescription cannabis-based medicines from the narcotics list and expanding patient access to the medical market. ANTG’s proactive approach has positioned them well in this evolving landscape.

Their ongoing success in Europe highlights the global potential of Australian medicinal cannabis.

Leave a Reply

Your email address will not be published. Required fields are marked *